|
Home
|
Issues
|
MJA shop
|
MJA Careers
|
Contact
|
Topics
|
Search
|
RSS |
Ian Stewart
While the medical disposables industry may benefit from labelling devices as "single use only", we all bear the costs of subsequent disposal and pollution.
MJA 1997; 167: 538-539
For editorial comment see Whitby & Looke
Introduction - Conclusion - References - Authors' details
Make a comment - Register to be notified of new articles by e-mail - Current contents list - ©MJA1997
Introduction |
Earlier this year, the National Health and Medical Research Council
(NHMRC) released its final report on the reuse of medical devices
labelled as "single use only". Australia's health ministers will now
be expected to decide which of the report's two main recommendations
is most appropriate: that either reuse of single-use devices should
cease altogether or, if reuse is condoned, the practice should be
subject to enforceable standards for cleaning, resterilisation and
quality control. The medical disposables industry is likely to lobby
politicians to adopt the former strategy, one which will require our
health ministers to find up to an estimated $100 million annually.1 In their deliberations,
another issue which ministers may wish to consider, which the NHMRC
report did not examine, is the process by which devices come to bear the
label "single use only".
Most of the debate about reuse of single-use devices has focused on expensive disposables such as cardiac catheters. Currently, such instruments are routinely reprocessed in many hospitals because the cost of disposal after each use would necessitate a reduction of services. The single-use status of devices such as angioplasty balloon catheters appears to be warranted, in that they are invasive devices with narrow lumens which may be difficult to clean and inspect. However, a randomised, double-blind, controlled clinical trial,2 cohort studies,3,4 and a risk-benefit assessment5 suggest that cardiac catheters can be safely reused if sound protocols for reprocessing are observed. There is not even any anecdotal evidence for the transmission of viral disease from the reuse of cardiac electrode catheters.6 Therefore, the evidence supporting the single-use status of apparently high risk cardiac catheters is unconvincing. Given this situation, how should we view the broad array of devices labelled "single use only" where criteria for disposability are tenuous at best, and most often knowingly inappropriate? Consider just a few examples from a long list of devices that I believe are spuriously labelled as "single use only". Disposable PVC oxygen masks. Used and discarded in considerable quantities every day in postoperative recovery rooms, most of these masks have a working life of about 10 minutes. They are not supplied as a sterile item (nor should they be) but the accompanying directions-for-use insert says "for single use only". In comparison, multiple-use black rubber anaesthetic masks (which are probably thought to do the same job from a microbiologist's perspective) are deemed safe for many uses. Disposable pressure infuser. This consists of a bladder with an external sleeve and an inflating bulb. A plastic bag of sterile fluid for flushing an artery or other vessel is placed inside the infuser sleeve and the bladder is inflated. The inside of the sealed bag is sterile; the external surface which is in contact with the infuser sleeve does not need to be sterile. The potential for nosocomial infection from this device is probably less than that of a blood pressure cuff, which is washed periodically, or immediately if soiled (a practice which should also apply to pressure infusers). Disposable nasal oxygen prongs. Even if staff insist on throwing away the nosepiece (which could be cleaned and pasteurised for reuse), why do the two metres of oxygen tubing need to be discarded? The answer is that the product is sold only as a single unit. It is difficult to see how design efficiency could be claimed to drive marketing decisions in this case because the oxygen tubing is of a larger diameter than the nasal prongs -- the two parts are bonded and sold as one. Single-patient-use oxygen transducers. A non-invasive device which is fitted to a finger or toe, this is a recent addition to the throw-away stable, and expensive at $26 (adult) or $34 (neonatal) each. They were formerly multiple-use devices that were easy to clean in detergent or with an alcohol swab. Pill cups, kidney trays, suction tubing, sequential calf compression cuffs and arm splints for intravenous lines also have low potential for cross-infection and would be easy to clean, inspect and, if necessary, resterilise. Perhaps little consideration is given to the mass consumption and disposal of such instruments because they are seen to be low-cost items. Yet this low cost is somewhat artificial, especially on the disposal side. In most hospitals, waste disposal is not costed to individual departments, so there are few incentives to minimise waste. Many of the indirect costs of waste disposal are passed on to the wider community. Incineration of chlorinated plastic releases carbon dioxide, dioxins and acid vapours into the atmosphere. The incremental costs of pollution monitoring and greenhouse warming, as well as the negative health effects and declining aesthetic value of decreased air quality, are not accounted for in the purchase price of biomedical disposables. Further, if it were a simple matter of supply and demand, clinicians would not be concerned about the opportunity costs of enforced disposal after one use, and health workers would not be worried about the environmental impact of all this unnecessary consumption and disposal of energy and resources. If there was a demand for durable, multiple-use devices, then surely entrepreneurial suppliers would rise to the occasion! However, the situation is more complex. John Kenneth Galbraith showed how suppliers can manipulate demand to suit their own ends.7 His exposure of the supply-and-demand myth is well represented by the culture of disposability which has taken root in modern healthcare over the last three decades, driven by the fear of litigation, so that non-invasive devices labelled "single use only" are treated as such without question. The infection-risk bogey and the spectre of litigation are raised in articles in nursing journals,8,9 central sterilising journals,10 pronouncements of the medical disposables industry,11 and in the mass media.12,13 The latter forum has a far-reaching capacity to muddy the waters; at least one television program linked the reuse of single-use medical devices with the HIV cross-infection of four women in a Sydney surgery, yet there was no suggestion that the surgeon involved deliberately reprocessed single-use devices.14 The virus was thought to have been transmitted through some unidentified breach of infection control guidelines,15 which is an entirely different issue. The process of cleaning, disinfecting and resterilising needs to be brought out into the open so that the current, somewhat surreptitious, practice of reprocessing single-use items can be guided by clear, commonsense protocols, quality controls and reporting of adverse events. However, the process by which biomedical devices come to carry the stamp of "single use only" should also be scrutinised. At present, these three words could be seen to be a licence to print money -- to my knowledge, manufacturers of single-use products do not have to explain why any device deserves to be labelled "disposable". The Industry Commission's 1996 report on the medical and scientific equipment industries16 reported that manufacturers have a financial incentive to label as "single use only" devices which may be safe to reuse. The Industry Commission suggested that market forces -- competition, threatened competition and the countervailing market power of more circumspect purchasing policies -- should put the brakes on this practice. With so much public money at issue, if governments decide to enforce single use more accountability should be required from the industry. If the industry has no interest in writing a code of labelling practice, then perhaps use of the words "single use only" should be regulated and licensed. |
Conclusion |
The NHMRC report on the reuse of medical devices labelled as "single
use only" examines a small part of a problem that deserves much wider
scrutiny; whether devices labelled "single use only" are to be
discarded or reused is only tinkering at the margins. The real agenda
should be a more thorough and open analysis of the costs and benefits of
using and reusing biomedical devices, including:
|
References |
|
Reprints will not be available from the author. Correspondence: Mr I
Stewart, PO Box 72, Erskineville, NSW 2043.
E-mail: I.Stewart AT unsw.edu.au
* Health Professionals for Global Responsibility is the NSW affiliate of the Medical Association for Prevention of War (Australia), affiliated with International Physicians for Prevention of Nuclear War.
|
Home
|
Issues
|
MJA shop
| Terms of use
|
MJA Careers
|
More...
|
Contact
|
Topics
|
Search
|
RSS |
<URL: http://www.mja.com.au/>
© 1997 Medical Journal of Australia.
We appreciate
your comments.